Table 2. Patterns and prevalence * of polypharmacy by age group and sex.
| 15-44 years | Prev. (%) | 45-64 years | Prev. (%) | ≥ 65 years | Prev. (%) | |
|---|---|---|---|---|---|---|
| Women | Depression-anxiety | 0.53 | Depression-anxiety | 11.90 | Depression-anxiety | 37.48 |
| ARI | 8.39 | Cardiovascular | 3.62 | Cardiovascular | 8.85 | |
| ARI | 7.39 | COPD | 7.41 | |||
| Menopause | 0.55 | |||||
| Men | Depression-anxiety | 0.78 | Depression-anxiety | 2.04 | Depression-anxiety | 0.29 |
| ARI | 3.55 | Cardiovascular | 10.85 | Cardiovascular | 24.63 | |
| Rhinitis-asthma | 0.09 | COPD | 5.18 | COPD | 25.34 | |
| Pain | 4.52 |
* Numerator: individuals with three or more drugs of the pattern within each age and sex group; Denominator: the entire population within each age and sex group.